๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This Phase 1/2 study evaluates the safety, tolerability, and preliminary an...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-02-04
Trial ID
NCT07480954
Treatments Being Tested
This illustrative Phase 1/Phase 2 study tests allogeneic dual-target GD2/B7...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07502287
Treatments Being Tested
This example study is an open-label, multi-center, adaptive Phase 1/2 trial...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07744256
Treatments Being Tested
This Phase 1/2 study evaluates the safety, tolerability, and preliminary an...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-02-02
Trial ID
NCT07589517
Treatments Being Tested
This example study evaluates the safety, feasibility, cellular kinetics, an...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07622940
Treatments Being Tested
This study tests the safety and preliminary anti-tumor activity of an inves...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-02-02
Trial ID
NCT07486089
Treatments Being Tested
This Phase 1/2 study evaluates the safety, feasibility, and preliminary ant...
Status
Recruiting
Location
District One Hospital
Start Date
2026-02-01
Trial ID
NCT07410494
Treatments Being Tested
This example Phase 1 study is designed to evaluate the safety, tolerability...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07641049
Treatments Being Tested
This example Phase 1/2 protocol evaluates allogeneic EGFR/HER2 dual-target ...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07617805
Treatments Being Tested
This is a first-in-human, open-label, multicenter phase 1/2 study evaluatin...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07627698
Treatments Being Tested